SCHEMBL31438680

SCHEMBL31438680

CC(C)[Si]1(C(C)C)OC[C@H]2O[C@@H](n3ccc(=O)n(C(=O)c4ccccc4)c3=O)[C@H](OCC(=O)O)[C@@H]2O[Si](C(C)C)(C(C)C)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13715793 0.90 — —
SCHEMBL18034297 0.90 — —
SCHEMBL12212813 0.86 — —
SCHEMBL25608885 0.86 P2RY6 (0.33) —
SCHEMBL1078117 0.76 — —
SCHEMBL1078788 0.76 — —
SCHEMBL1592652 0.75 — —
SCHEMBL6365679 0.74 POLB (0.45) —
SCHEMBL7726485 0.74 POLB (0.42) —
SCHEMBL12701557 0.73 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025038971-A1 OLIGONUCLEOTIDES CONTAINING A LIGAND AT A NUCLEOBASE, 2' POSITION, OR 3' POSITION ADARX PHARMACEUTICALS, INC. (US) 2025-02-20 — — WO disclosed
Send feedback